Free Trial

Diversified Healthcare Trust (DHC) Financials

Diversified Healthcare Trust logo
$2.24 +0.11 (+4.93%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$2.24 +0.01 (+0.45%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Diversified Healthcare Trust

Annual Income Statements for Diversified Healthcare Trust

This table shows Diversified Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-16 -294 -370
Consolidated Net Income / (Loss)
-16 -294 -370
Net Income / (Loss) Continuing Operations
-16 -294 -370
Total Pre-Tax Income
-21 -273 -371
Total Operating Income
-94 -103 -126
Total Gross Profit
1,284 1,410 1,495
Total Revenue
1,284 1,410 1,495
Operating Revenue
1,284 1,410 1,495
Total Cost of Revenue
0.00 0.00 0.00
Total Operating Expenses
1,377 1,514 1,621
Selling, General & Admin Expense
1,136 1,200 1,263
Depreciation Expense
239 284 285
Impairment Charge
0.00 18 71
Restructuring Charge
2.61 11 2.51
Total Other Income / (Expense), net
73 -169 -246
Interest Expense
239 194 236
Interest & Investment Income
16 24 8.95
Other Income / (Expense), net
296 1.21 -19
Income Tax Expense
0.71 0.45 0.47
Other Gains / (Losses), net
6.06 -20 1.60
Basic Earnings per Share
($0.07) ($1.23) ($1.55)
Weighted Average Basic Shares Outstanding
238.31M 238.84M 239.54M
Diluted Earnings per Share
($0.07) ($1.23) ($1.55)
Weighted Average Diluted Shares Outstanding
238.31M 238.84M 239.54M
Weighted Average Basic & Diluted Shares Outstanding
239.68M 240.42M 241.27M
Cash Dividends to Common per Share
$0.04 $0.04 $0.04

Quarterly Income Statements for Diversified Healthcare Trust

This table shows Diversified Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-81 -65 -53 -73 -66 -103 -86 -98 -99 -87
Consolidated Net Income / (Loss)
-81 -65 -53 -73 -66 -103 -86 -98 -99 -87
Net Income / (Loss) Continuing Operations
-81 -65 -53 -73 -66 -103 -86 -98 -99 -87
Total Pre-Tax Income
-84 -63 -52 -75 -65 -80 -88 -85 -99 -99
Total Operating Income
-33 -18 -17 -33 -21 -33 -27 -16 -42 -41
Total Gross Profit
323 337 346 346 357 362 371 371 374 380
Total Revenue
323 337 346 346 357 362 371 371 374 380
Operating Revenue
323 337 346 346 357 362 371 371 374 380
Total Operating Expenses
356 355 363 379 377 394 398 387 416 421
Selling, General & Admin Expense
295 291 292 294 305 309 315 310 324 314
Depreciation Expense
60 63 65 68 67 84 70 68 69 78
Impairment Charge
0.00 - 5.93 11 1.16 - 12 6.55 23 29
Restructuring Charge
0.29 0.78 0.09 6.04 3.68 1.04 0.09 1.83 0.33 0.27
Total Other Income / (Expense), net
-51 -45 -35 -42 -45 -47 -61 -70 -57 -58
Interest Expense
47 49 49 47 48 50 58 59 59 60
Interest & Investment Income
1.43 22 12 5.13 3.24 2.96 2.24 2.40 2.58 1.74
Other Income / (Expense), net
-5.04 -17 1.23 0.00 0.00 -0.03 -5.87 -13 0.11 0.04
Income Tax Expense
0.01 -0.14 -0.03 0.22 0.19 0.07 0.19 0.17 0.15 -0.04
Other Gains / (Losses), net
2.13 -2.63 -0.65 2.93 -0.15 -23 1.90 -12 0.53 11
Basic Earnings per Share
($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37)
Weighted Average Basic Shares Outstanding
238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M
Diluted Earnings per Share
($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37)
Weighted Average Diluted Shares Outstanding
238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M
Weighted Average Basic & Diluted Shares Outstanding
239.70M 239.68M 239.68M 239.79M 240.45M 240.42M 240.39M 240.57M 241.28M 241.27M

Annual Cash Flow Statements for Diversified Healthcare Trust

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
-329 -441 -97
Net Cash From Operating Activities
-40 10 112
Net Cash From Continuing Operating Activities
-40 10 112
Net Income / (Loss) Continuing Operations
-16 -294 -370
Consolidated Net Income / (Loss)
-16 -294 -370
Depreciation Expense
239 284 285
Amortization Expense
8.90 12 104
Non-Cash Adjustments To Reconcile Net Income
-274 36 87
Changes in Operating Assets and Liabilities, net
1.64 -28 6.82
Net Cash From Investing Activities
388 -202 -187
Net Cash From Continuing Investing Activities
388 -202 -187
Purchase of Property, Plant & Equipment
-299 -235 -202
Acquisitions
-75 0.00 -21
Sale of Property, Plant & Equipment
0.82 18 34
Divestitures
108 0.00 0.00
Sale and/or Maturity of Investments
638 0.00 0.00
Other Investing Activities, net
14 15 1.70
Net Cash From Financing Activities
-676 -250 -22
Net Cash From Continuing Financing Activities
-676 -250 -22
Repayment of Debt
-666 -990 -132
Repurchase of Common Equity
-0.17 -0.39 -0.90
Payment of Dividends
-9.57 -9.60 -9.63
Issuance of Debt
0.00 750 120

Quarterly Cash Flow Statements for Diversified Healthcare Trust

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-68 -113 -306 -26 -78 -32 -39 62 -8.69 -112
Net Cash From Operating Activities
-5.09 -3.41 6.04 26 -14 -7.21 29 44 21 18
Net Cash From Continuing Operating Activities
-5.09 -3.41 6.04 26 -14 -7.21 29 44 21 18
Net Income / (Loss) Continuing Operations
-81 -65 -53 -73 -66 -103 -86 -98 -99 -87
Consolidated Net Income / (Loss)
-81 -65 -53 -73 -66 -103 -86 -98 -99 -87
Depreciation Expense
60 63 65 68 67 84 70 68 69 78
Amortization Expense
1.95 2.00 1.76 2.27 2.32 5.22 25 26 26 27
Non-Cash Adjustments To Reconcile Net Income
4.12 6.09 -3.42 14 1.58 24 17 32 22 17
Changes in Operating Assets and Liabilities, net
9.92 -9.53 -4.44 14 -19 -18 3.16 17 2.93 -16
Net Cash From Investing Activities
-44 -96 -57 -34 -60 -51 -59 -37 -25 -66
Net Cash From Continuing Investing Activities
-44 -96 -57 -34 -60 -51 -59 -37 -25 -66
Purchase of Property, Plant & Equipment
-72 -110 -60 -48 -60 -67 -47 -41 -47 -67
Acquisitions
- - 0.00 - - - -15 - - -5.72
Sale of Property, Plant & Equipment
0.03 - 3.55 - - 15 3.34 3.98 21 6.32
Net Cash From Financing Activities
-19 -13 -255 -18 -3.48 26 -8.56 54 -4.63 -64
Net Cash From Continuing Financing Activities
-19 -13 -255 -18 -3.48 26 -8.56 54 -4.63 -64
Repayment of Debt
-16 -11 -253 -15 -0.73 -721 -6.08 -63 -1.44 -61
Repurchase of Common Equity
-0.16 -0.01 -0.01 -0.03 -0.35 -0.01 -0.08 -0.04 -0.78 -0.00
Payment of Dividends
-2.39 -2.40 -2.40 -2.40 -2.40 -2.40 -2.40 -2.40 -2.41 -2.41

Annual Balance Sheets for Diversified Healthcare Trust

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Total Assets
6,002 5,446 5,137
Total Current Assets
667 253 149
Cash & Equivalents
658 246 145
Accounts Receivable
8.72 6.08 4.06
Plant, Property, & Equipment, net
4,864 4,798 4,340
Plant, Property & Equipment, gross
6,693 6,818 6,423
Accumulated Depreciation
1,828 2,021 2,083
Total Noncurrent Assets
471 395 648
Long-Term Investments
161 130 151
Intangible Assets
45 34 26
Other Noncurrent Operating Assets
264 232 470
Total Liabilities & Shareholders' Equity
6,002 5,446 5,137
Total Liabilities
3,363 3,109 3,178
Total Current Liabilities
0.00 0.03 0.00
Total Noncurrent Liabilities
3,363 3,089 3,178
Long-Term Debt
3,018 2,804 2,784
Other Noncurrent Operating Liabilities
346 285 388
Other Noncurrent Nonoperating Liabilities
0.00 - 6.02
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,639 2,337 1,959
Total Preferred & Common Equity
2,639 2,337 1,959
Total Common Equity
2,639 2,337 1,959
Common Stock
4,619 4,621 4,623
Retained Earnings
2,072 1,778 1,408
Accumulated Other Comprehensive Income / (Loss)
- 0.00 -0.02
Other Equity Adjustments
-4,053 -4,062 -4,072

Quarterly Balance Sheets for Diversified Healthcare Trust

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
6,072 5,667 5,585 5,530 5,348 5,333 5,285
Total Current Assets
801 383 357 279 208 266 257
Cash & Equivalents
691 380 338 278 207 266 257
Plant, Property, & Equipment, net
4,812 4,845 4,804 4,801 4,709 4,655 4,562
Plant, Property & Equipment, gross
6,597 6,724 6,712 6,767 6,771 6,762 6,673
Accumulated Depreciation
1,785 1,879 1,908 1,966 2,062 2,107 2,111
Total Noncurrent Assets
460 439 425 450 431 413 467
Long-Term Investments
159 153 155 154 146 134 134
Intangible Assets
48 42 39 37 32 30 28
Other Noncurrent Operating Assets
252 244 230 260 253 250 305
Total Liabilities & Shareholders' Equity
6,072 5,667 5,585 5,530 5,348 5,333 5,285
Total Liabilities
3,366 3,083 3,076 3,089 3,099 3,184 3,237
Total Current Liabilities
700 450 450 450 0.22 0.00 0.00
Total Noncurrent Liabilities
2,666 2,633 2,626 2,638 3,087 3,184 3,237
Long-Term Debt
2,357 2,348 2,335 2,335 2,826 2,920 2,945
Other Noncurrent Operating Liabilities
308 284 291 303 261 264 289
Other Noncurrent Nonoperating Liabilities
- - - - - 0.58 2.62
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,706 2,584 2,509 2,442 2,249 2,149 2,048
Total Preferred & Common Equity
2,706 2,584 2,509 2,442 2,249 2,149 2,048
Total Common Equity
2,706 2,584 2,509 2,442 2,249 2,149 2,048
Common Stock
4,619 4,620 4,620 4,621 4,621 4,622 4,622
Retained Earnings
2,137 2,019 1,947 1,881 1,692 1,594 1,495
Accumulated Other Comprehensive Income / (Loss)
- - - - -0.00 -0.03 0.01
Other Equity Adjustments
-4,050 -4,055 -4,057 -4,060 -4,065 -4,067 -4,069

Annual Metrics and Ratios for Diversified Healthcare Trust

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
-7.20% 9.87% 6.04%
EBITDA Growth
-71.86% -57.04% 25.91%
EBIT Growth
-56.11% -150.44% -41.82%
NOPAT Growth
-177.62% -10.09% -21.83%
Net Income Growth
-108.77% -1,761.11% -26.12%
EPS Growth
-109.59% -1,657.14% -26.02%
Operating Cash Flow Growth
36.27% 125.98% 970.52%
Free Cash Flow Firm Growth
-81.19% -111.21% 1,353.20%
Invested Capital Growth
-4.70% -1.09% -6.92%
Revenue Q/Q Growth
0.01% 1.78% 1.22%
EBITDA Q/Q Growth
244.82% 15.78% 2.96%
EBIT Q/Q Growth
265.16% 2.73% -6.20%
NOPAT Q/Q Growth
46.24% -16.22% -7.26%
Net Income Q/Q Growth
-103.79% -14.53% 3.92%
EPS Q/Q Growth
-104.02% -13.89% 3.73%
Operating Cash Flow Q/Q Growth
53.66% -26.63% 29.26%
Free Cash Flow Firm Q/Q Growth
-83.18% 62.67% 128.05%
Invested Capital Q/Q Growth
1.47% -0.21% -3.31%
Profitability Metrics
- - -
Gross Margin
200.00% 100.00% 100.00%
EBITDA Margin
35.10% 13.73% 16.30%
Operating Margin
10.46% -7.32% -8.41%
EBIT Margin
33.53% -7.24% -9.68%
Profit (Net Income) Margin
-1.23% -20.82% -24.76%
Tax Burden Percent
74.69% 107.67% 99.70%
Interest Burden Percent
-19.70% 267.10% 256.53%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-1.33% -1.50% -1.91%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -11.03% -13.33%
Return on Net Nonoperating Assets (RNNOA)
0.00% -10.30% -15.33%
Return on Equity (ROE)
0.00% -11.80% -17.24%
Cash Return on Invested Capital (CROIC)
3.49% -0.40% 5.26%
Operating Return on Assets (OROA)
3.21% -1.78% -2.74%
Return on Assets (ROA)
-0.25% -5.13% -7.00%
Return on Common Equity (ROCE)
0.00% -11.80% -17.24%
Return on Equity Simple (ROE_SIMPLE)
-0.60% -12.56% -18.90%
Net Operating Profit after Tax (NOPAT)
-66 -72 -88
NOPAT Margin
7.32% -5.13% -5.89%
Net Nonoperating Expense Percent (NNEP)
-2.16% 9.53% 11.42%
Return On Investment Capital (ROIC_SIMPLE)
-1.16% -1.41% -1.86%
Cost of Revenue to Revenue
0.00% 0.00% 0.00%
SG&A Expenses to Revenue
88.46% 85.11% 84.46%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
214.62% 107.32% 108.41%
Earnings before Interest and Taxes (EBIT)
202 -102 -145
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
451 194 244
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.06 0.38 0.28
Price to Tangible Book Value (P/TBV)
0.06 0.38 0.29
Price to Revenue (P/Rev)
0.23 0.63 0.37
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
13.03% 1.09% 1.75%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.48 0.69 0.68
Enterprise Value to Revenue (EV/Rev)
1.83 2.35 2.03
Enterprise Value to EBITDA (EV/EBITDA)
10.41 17.10 12.48
Enterprise Value to EBIT (EV/EBIT)
11.59 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 315.72 27.09
Enterprise Value to Free Cash Flow (EV/FCFF)
27.16 0.00 12.53
Leverage & Solvency
- - -
Debt to Equity
0.00 1.20 1.42
Long-Term Debt to Equity
0.00 1.20 1.42
Financial Leverage
0.00 0.93 1.15
Leverage Ratio
0.00 2.30 2.46
Compound Leverage Factor
0.00 6.15 6.32
Debt to Total Capital
53.35% 54.54% 58.70%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
53.35% 54.54% 58.70%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
46.65% 45.46% 41.30%
Debt to EBITDA
6.70 14.49 11.42
Net Debt to EBITDA
9.76 12.54 10.21
Long-Term Debt to EBITDA
13.40 14.49 11.42
Debt to NOPAT
-26.85 -38.78 -31.61
Net Debt to NOPAT
-19.66 -33.57 -28.25
Long-Term Debt to NOPAT
-45.95 -38.78 -31.61
Altman Z-Score
0.00 0.88 0.72
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
0.00 7,907.56 0.00
Quick Ratio
0.00 7,875.63 0.00
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
173 -19 243
Operating Cash Flow to CapEx
-13.52% 4.84% 66.98%
Free Cash Flow to Firm to Interest Expense
2.36 -0.10 1.03
Operating Cash Flow to Interest Expense
-0.17 0.05 0.48
Operating Cash Flow Less CapEx to Interest Expense
-1.42 -1.06 -0.23
Efficiency Ratios
- - -
Asset Turnover
0.20 0.25 0.28
Accounts Receivable Turnover
0.00 190.62 295.01
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
0.26 0.29 0.33
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 1.91 1.24
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 1.91 1.24
Capital & Investment Metrics
- - -
Invested Capital
4,837 4,784 4,453
Invested Capital Turnover
0.26 0.29 0.32
Increase / (Decrease) in Invested Capital
-238 -53 -331
Enterprise Value (EV)
2,346 3,310 3,041
Market Capitalization
147 883 552
Book Value per Share
$11.01 $9.72 $8.12
Tangible Book Value per Share
$10.82 $9.58 $8.01
Total Capital
5,656 5,141 4,743
Total Debt
3,018 2,804 2,784
Total Long-Term Debt
3,018 2,804 2,784
Net Debt
2,198 2,427 2,488
Capital Expenditures (CapEx)
299 217 168
Debt-free, Cash-free Net Working Capital (DFCFNWC)
8.72 6.05 4.06
Debt-free Net Working Capital (DFNWC)
667 253 149
Net Working Capital (NWC)
667 253 149
Net Nonoperating Expense (NNE)
-50 221 282
Net Nonoperating Obligations (NNO)
2,198 2,447 2,494
Total Depreciation and Amortization (D&A)
248 296 389
Debt-free, Cash-free Net Working Capital to Revenue
1.36% 0.43% 0.27%
Debt-free Net Working Capital to Revenue
105.57% 17.94% 9.94%
Net Working Capital to Revenue
103.90% 17.94% 9.94%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($0.07) ($1.23) ($1.55)
Adjusted Weighted Average Basic Shares Outstanding
238.31M 238.84M 239.54M
Adjusted Diluted Earnings per Share
($0.07) ($1.23) ($1.55)
Adjusted Weighted Average Diluted Shares Outstanding
238.31M 238.84M 239.54M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
239.68M 240.42M 241.27M
Normalized Net Operating Profit after Tax (NOPAT)
-64 -52 -37
Normalized NOPAT Margin
-9.95% -3.68% -2.46%
Pre Tax Income Margin
-3.29% -19.33% -24.83%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.85 -0.53 -0.61
NOPAT to Interest Expense
0.39 -0.37 -0.37
EBIT Less CapEx to Interest Expense
-0.40 -1.64 -1.33
NOPAT Less CapEx to Interest Expense
-0.85 -1.49 -1.09
Payout Ratios
- - -
Dividend Payout Ratio
-60.66% -3.27% -2.60%
Augmented Payout Ratio
-61.74% -3.40% -2.84%

Quarterly Metrics and Ratios for Diversified Healthcare Trust

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-4.30% 0.05% 11.36% 10.60% 10.41% 7.32% 7.15% 7.27% 4.80% 5.00%
EBITDA Growth
-48.28% 27.18% -85.64% -7.83% 100.40% 88.34% 22.15% 73.04% 8.95% 12.46%
EBIT Growth
-59.45% 24.32% -105.24% -66.80% 45.06% 8.08% -110.41% 12.57% -101.62% -25.90%
NOPAT Growth
-253.98% 72.83% 49.78% -72.79% 36.67% -79.29% -59.83% 52.58% -102.15% -26.12%
Net Income Growth
7.40% -117.81% -121.90% 33.65% 19.28% -57.01% -63.81% -34.85% -50.03% 14.74%
EPS Growth
10.53% -118.30% -121.78% 34.78% 17.65% -53.57% -63.64% -36.67% -46.43% 13.95%
Operating Cash Flow Growth
87.35% 93.21% 183.18% 204.43% -175.55% -111.72% 373.39% 72.47% 250.62% 352.39%
Free Cash Flow Firm Growth
609.33% -75.00% -110.65% -97.34% -100.38% -86.65% 169.11% 224.87% 3,773.50% 902.85%
Invested Capital Growth
-19.30% -4.70% 2.66% -1.12% -0.21% -1.09% -2.35% -2.33% -3.93% -6.92%
Revenue Q/Q Growth
3.16% 4.32% 2.71% 0.05% 2.98% 1.41% 2.56% 0.17% 0.61% 1.60%
EBITDA Q/Q Growth
-40.59% 1,467.78% 70.94% -26.28% 29.18% 15.69% 10.87% 4.43% -18.66% 19.42%
EBIT Q/Q Growth
-92.39% 919.07% 56.30% -112.98% 36.63% -55.84% -0.04% 11.51% -46.14% 2.69%
NOPAT Q/Q Growth
-72.91% 1,063.84% 7.90% -97.29% 36.63% -55.71% 17.90% 41.46% -170.13% 2.86%
Net Income Q/Q Growth
25.50% 19.84% 19.39% -37.82% 9.36% -55.92% 15.90% -13.45% -0.85% 11.39%
EPS Q/Q Growth
26.09% 17.65% 21.43% -36.36% 6.67% -53.57% 16.28% -13.89% 0.00% 9.76%
Operating Cash Flow Q/Q Growth
79.29% 33.13% 277.44% 325.04% -154.64% 48.62% 496.75% 54.86% -52.28% -13.91%
Free Cash Flow Firm Q/Q Growth
-3.21% -79.96% -160.86% 122.52% -113.99% 796.09% 215.14% 5.87% 58.17% 90.03%
Invested Capital Q/Q Growth
-0.65% 1.47% 0.19% -1.33% 0.25% -0.21% -1.07% -1.31% -1.39% -3.31%
Profitability Metrics
- - - - - - - - - -
Gross Margin
100.00% 100.00% 200.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
7.51% 8.87% 29.51% 10.87% 13.64% 15.56% 16.82% 17.54% 14.18% 16.66%
Operating Margin
-10.24% -5.40% -9.32% -9.54% -5.87% -9.01% -7.22% -4.22% -11.32% -10.83%
EBIT Margin
-11.80% -10.53% -8.96% -9.54% -5.87% -9.02% -8.80% -7.78% -11.29% -10.82%
Profit (Net Income) Margin
-25.24% -19.39% -15.22% -20.96% -18.45% -28.37% -23.26% -26.35% -26.41% -23.04%
Tax Burden Percent
97.47% 0.00% 202.37% 96.40% 100.51% 128.37% 98.06% 114.61% 99.62% 88.36%
Interest Burden Percent
219.47% 177.05% 335.58% 227.92% 312.69% 244.96% 269.59% 295.69% 234.76% 240.99%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-1.71% -0.98% -0.93% -1.88% -1.19% -1.85% -1.51% -0.91% -2.49% -2.45%
ROIC Less NNEP Spread (ROIC-NNEP)
-3.78% -3.26% -2.94% -4.17% -3.48% -5.28% -4.36% -4.54% -5.31% -4.83%
Return on Net Nonoperating Assets (RNNOA)
-4.17% -2.84% -2.19% -3.40% -3.01% -4.93% -4.28% -4.67% -5.80% -5.55%
Return on Equity (ROE)
-5.88% -3.81% -3.12% -5.27% -4.20% -6.78% -5.80% -5.58% -8.29% -8.01%
Cash Return on Invested Capital (CROIC)
19.10% 3.49% -3.07% -0.35% -1.08% -0.40% 0.72% 0.94% 2.26% 5.26%
Operating Return on Assets (OROA)
-2.30% -2.14% -0.95% -2.20% -1.40% -2.22% -2.29% -2.08% -3.09% -3.06%
Return on Assets (ROA)
-4.93% -3.94% -3.23% -4.83% -4.41% -6.99% -6.06% -7.05% -7.22% -6.51%
Return on Common Equity (ROCE)
-5.75% -3.81% -3.12% -5.27% -4.20% -6.78% -5.80% -5.58% -8.29% -8.01%
Return on Equity Simple (ROE_SIMPLE)
15.38% 0.00% -11.95% -10.84% -10.50% 0.00% -14.55% -16.40% -18.81% 0.00%
Net Operating Profit after Tax (NOPAT)
-23 -13 -12 -23 -15 -23 -19 -11 -30 -29
NOPAT Margin
-7.16% -3.78% -3.39% -6.68% -4.11% -6.31% -5.05% -2.95% -7.93% -7.58%
Net Nonoperating Expense Percent (NNEP)
2.07% 2.28% 2.01% 2.29% 2.30% 3.43% 2.85% 3.63% 2.81% 2.37%
Return On Investment Capital (ROIC_SIMPLE)
-0.40% -0.23% -0.22% -0.44% -0.28% -0.44% -0.37% -0.22% -0.59% -0.61%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
91.44% 86.36% 168.74% 84.78% 85.66% 85.59% 85.00% 83.56% 86.62% 82.70%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
110.24% 105.40% 209.68% 109.54% 105.87% 109.01% 107.22% 104.22% 111.32% 110.83%
Earnings before Interest and Taxes (EBIT)
-38 -35 -16 -33 -21 -33 -33 -29 -42 -41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
24 30 51 38 49 56 62 65 53 63
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.08 0.06 0.24 0.21 0.19 0.38 0.26 0.34 0.49 0.28
Price to Tangible Book Value (P/TBV)
0.08 0.06 0.25 0.21 0.19 0.38 0.26 0.34 0.50 0.29
Price to Revenue (P/Rev)
0.17 0.23 0.24 0.39 0.33 0.63 0.41 0.50 0.68 0.37
Price to Earnings (P/E)
0.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
4.29% 13.03% 6.15% 1.83% 2.11% 1.09% 1.65% 1.33% 0.96% 1.75%
Earnings Yield
186.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.48 0.48 1.06 0.58 0.59 0.69 0.65 0.70 0.77 0.68
Enterprise Value to Revenue (EV/Rev)
1.81 1.83 1.95 2.07 2.03 2.35 2.13 2.22 2.41 2.03
Enterprise Value to EBITDA (EV/EBITDA)
17.76 10.41 17.63 19.58 16.79 17.10 14.91 13.97 15.02 12.48
Enterprise Value to EBIT (EV/EBIT)
0.00 11.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 120.42 196.43 315.72 92.43 62.84 40.95 27.09
Enterprise Value to Free Cash Flow (EV/FCFF)
2.26 13.58 0.00 0.00 0.00 0.00 88.95 73.27 33.40 12.53
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.13 1.14 2.17 1.11 1.14 1.20 1.26 1.36 1.44 1.42
Long-Term Debt to Equity
0.87 1.14 1.82 0.93 0.96 1.20 1.26 1.36 1.44 1.42
Financial Leverage
1.10 0.87 1.49 0.82 0.86 0.93 0.98 1.03 1.09 1.15
Leverage Ratio
2.57 2.38 4.54 2.21 2.25 2.30 2.28 2.34 2.41 2.46
Compound Leverage Factor
5.64 4.22 15.23 5.05 7.05 5.64 6.14 6.93 5.65 5.94
Debt to Total Capital
53.06% 53.35% 103.99% 52.60% 53.29% 54.54% 55.68% 57.60% 58.98% 58.70%
Short-Term Debt to Total Capital
12.14% 0.00% 16.72% 8.50% 8.61% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
40.92% 53.35% 43.63% 44.10% 44.68% 54.54% 55.68% 57.60% 58.98% 58.70%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
46.94% 46.65% 48.01% 47.40% 46.71% 45.46% 44.32% 42.40% 41.02% 41.30%
Debt to EBITDA
23.41 6.70 19.17 19.50 16.66 14.49 13.79 12.57 12.44 11.42
Net Debt to EBITDA
16.06 4.88 15.49 15.91 14.07 12.54 12.06 10.85 10.79 10.21
Long-Term Debt to EBITDA
18.05 6.70 16.08 16.35 13.97 14.49 13.79 12.57 12.44 11.42
Debt to NOPAT
-25.04 -45.95 -45.91 -39.39 -44.76 -38.78 -35.63 -43.48 -35.86 -31.61
Net Debt to NOPAT
-17.18 -33.47 -37.11 -32.14 -37.81 -33.57 -31.16 -37.53 -31.11 -28.25
Long-Term Debt to NOPAT
-19.31 -45.95 -38.53 -33.02 -37.53 -38.78 -35.63 -43.48 -35.86 -31.61
Altman Z-Score
0.74 0.84 0.77 0.79 0.77 0.92 0.85 0.87 0.89 0.79
Noncontrolling Interest Sharing Ratio
2.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.14 0.00 0.85 0.79 0.62 7,907.56 954.88 0.00 0.00 0.00
Quick Ratio
0.99 0.00 1.69 0.75 0.62 7,875.63 950.11 0.00 0.00 0.00
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,126 226 -137 31 -4.33 30 95 100 159 302
Operating Cash Flow to CapEx
-7.03% -3.09% 10.65% 53.90% -23.20% -13.92% 65.93% 119.64% 79.10% 30.12%
Free Cash Flow to Firm to Interest Expense
23.99 4.57 -2.81 0.65 -0.09 0.60 1.65 1.71 2.67 5.07
Operating Cash Flow to Interest Expense
-0.11 -0.07 0.12 0.54 -0.29 -0.14 0.50 0.75 0.36 0.31
Operating Cash Flow Less CapEx to Interest Expense
-1.65 -2.30 -1.04 -0.46 -1.56 -1.17 -0.26 0.12 -0.09 -0.71
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.20 0.20 0.21 0.23 0.24 0.25 0.26 0.27 0.27 0.28
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 190.62 0.00 0.00 0.00 295.01
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.24 0.26 0.28 0.28 0.29 0.29 0.30 0.31 0.32 0.33
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 1.91 0.00 0.00 0.00 1.24
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 1.91 0.00 0.00 0.00 1.24
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
4,804 4,837 4,846 4,782 4,794 4,784 4,733 4,671 4,606 4,453
Invested Capital Turnover
0.24 0.26 0.28 0.28 0.29 0.29 0.30 0.31 0.31 0.32
Increase / (Decrease) in Invested Capital
-1,149 -238 126 -54 -10 -53 -114 -111 -189 -331
Enterprise Value (EV)
2,321 4,700 2,574 2,797 2,806 3,310 3,054 3,246 3,555 3,041
Market Capitalization
223 147 630 525 454 883 583 725 1,000 552
Book Value per Share
$11.32 $11.01 $10.78 $10.47 $10.18 $9.72 $9.40 $8.94 $8.51 $8.12
Tangible Book Value per Share
$11.11 $10.82 $10.60 $10.31 $10.03 $9.58 $9.27 $8.82 $8.40 $8.01
Total Capital
5,765 5,656 5,382 5,294 5,227 5,141 5,074 5,069 4,994 4,743
Total Debt
3,059 3,018 2,798 2,785 2,785 2,804 2,826 2,920 2,945 2,784
Total Long-Term Debt
2,359 3,018 2,348 2,335 2,335 2,804 2,826 2,920 2,945 2,784
Net Debt
2,098 2,198 2,262 2,272 2,352 2,427 2,471 2,521 2,554 2,488
Capital Expenditures (CapEx)
72 110 57 48 60 52 43 37 27 60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 8.72 0.00 -0.31 -0.43 6.05 -0.22 0.00 0.00 4.06
Debt-free Net Working Capital (DFNWC)
801 667 383 357 279 253 208 266 257 149
Net Working Capital (NWC)
101 667 -67 -93 -171 253 208 266 257 149
Net Nonoperating Expense (NNE)
58 53 41 49 51 80 68 87 69 59
Net Nonoperating Obligations (NNO)
2,098 2,198 2,262 2,273 2,353 2,447 2,484 2,521 2,557 2,494
Total Depreciation and Amortization (D&A)
62 65 67 71 70 89 95 94 95 104
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.68% 0.00% -0.02% -0.03% 0.43% -0.02% 0.00% 0.00% 0.27%
Debt-free Net Working Capital to Revenue
62.40% 51.95% 29.02% 26.39% 20.11% 17.94% 14.49% 18.19% 17.36% 9.94%
Net Working Capital to Revenue
7.85% 103.90% -5.11% -6.89% -12.36% 17.94% 14.49% 18.19% 17.36% 9.94%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37)
Adjusted Weighted Average Basic Shares Outstanding
238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M
Adjusted Diluted Earnings per Share
($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37)
Adjusted Weighted Average Diluted Shares Outstanding
238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
239.70M 239.68M 239.68M 239.79M 240.45M 240.42M 240.39M 240.57M 241.28M 241.27M
Normalized Net Operating Profit after Tax (NOPAT)
-23 -12 -7.51 -11 -11 -22 -10 -5.10 -13 -8.27
Normalized NOPAT Margin
-7.10% -3.62% -2.17% -3.17% -3.16% -6.11% -2.74% -1.37% -3.55% -2.18%
Pre Tax Income Margin
-25.89% -18.65% -30.08% -21.74% -18.36% -22.10% -23.73% -22.99% -26.51% -26.07%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-0.81 -0.72 -0.63 -0.70 -0.44 -0.65 -0.57 -0.49 -0.71 -0.69
NOPAT to Interest Expense
-0.49 -0.26 -0.46 -0.49 -0.31 -0.45 -0.33 -0.19 -0.50 -0.48
EBIT Less CapEx to Interest Expense
-2.36 -2.95 -1.80 -1.70 -1.70 -1.68 -1.32 -1.12 -1.16 -1.70
NOPAT Less CapEx to Interest Expense
-2.04 -2.49 -1.62 -1.49 -1.57 -1.48 -1.08 -0.81 -0.95 -1.50
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
3.62% -60.66% -3.10% -3.52% -3.74% -3.27% -2.93% -2.73% -2.50% -2.60%
Augmented Payout Ratio
3.66% -61.74% -3.16% -3.60% -3.89% -3.40% -3.08% -2.86% -2.73% -2.84%

Frequently Asked Questions About Diversified Healthcare Trust's Financials

When does Diversified Healthcare Trust's fiscal year end?

According to the most recent income statement we have on file, Diversified Healthcare Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Diversified Healthcare Trust's net income changed over the last 2 years?

Diversified Healthcare Trust's net income appears to be on an upward trend, with a most recent value of -$370.26 million in 2024, rising from -$15.77 million in 2022. The previous period was -$293.57 million in 2023.

What is Diversified Healthcare Trust's operating income?
Diversified Healthcare Trust's total operating income in 2024 was -$125.83 million, based on the following breakdown:
  • Total Gross Profit: $1.50 billion
  • Total Operating Expenses: $1.62 billion
How has Diversified Healthcare Trust revenue changed over the last 2 years?

Over the last 2 years, Diversified Healthcare Trust's total revenue changed from $1.28 billion in 2022 to $1.50 billion in 2024, a change of 16.5%.

How much debt does Diversified Healthcare Trust have?

Diversified Healthcare Trust's total liabilities were at $3.18 billion at the end of 2024, a 2.2% increase from 2023, and a 5.5% decrease since 2022.

How much cash does Diversified Healthcare Trust have?

In the past 2 years, Diversified Healthcare Trust's cash and equivalents has ranged from $144.58 million in 2024 to $658.07 million in 2022, and is currently $144.58 million as of their latest financial filing in 2024.

How has Diversified Healthcare Trust's book value per share changed over the last 2 years?

Over the last 2 years, Diversified Healthcare Trust's book value per share changed from 11.01 in 2022 to 8.12 in 2024, a change of -26.2%.



This page (NASDAQ:DHC) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners